Spotlight: Jan 15, 2026
A hallmark of Alzheimer’s disease is the clumping of so-called Tau proteins in the brain. Chemists have deciphered the structure of the “fuzzy” molecular coat around these proteins, which may aid efforts to develop drugs that interfere with Tau buildup.